Salmonellosis cost-effectiveness of therapy: Difference between revisions
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Although most cases of salmonellosis are not complicated, supportive and symptomatic treatment are mandatory in order to avoid worsening of the condition. Additionally, salmonellosis may incapacitate the affected persons for several days, jeopardizing their ability to work. Therefore, the treatment and prevention of salmonellosis may be considered cost-effective. | |||
==References== | ==References== | ||
Revision as of 22:46, 20 August 2014
|
Salmonellosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Salmonellosis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Salmonellosis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Salmonellosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
Overview
Although most cases of salmonellosis are not complicated, supportive and symptomatic treatment are mandatory in order to avoid worsening of the condition. Additionally, salmonellosis may incapacitate the affected persons for several days, jeopardizing their ability to work. Therefore, the treatment and prevention of salmonellosis may be considered cost-effective.